Bengsch Bertram, Ohtani Takuya, Khan Omar, Setty Manu, Manne Sasikanth, O'Brien Shaun, Gherardini Pier Federico, Herati Ramin Sedaghat, Huang Alexander C, Chang Kyong-Mi, Newell Evan W, Bovenschen Niels, Pe'er Dana, Albelda Steven M, Wherry E John Epigenomic-Guided Mass Cytometry Profiling Reveals Disease-Specific Features of Exhausted CD8 T Cells. , Immunity, 48(5): 2018,1029-1045.e5

Aggarwal Charu, Haas Andrew R, Metzger Susan, Aguilar Laura K, Aguilar-Cordova Estuardo, Manzanera Andrea G, Gómez-Hernández Gregoria, Katz Sharyn I, Alley Evan W, Evans Tracey L, Bauml Joshua M, Cohen Roger B, Langer Corey J, Albelda Steven M, Sterman Daniel H Phase I Study of Intrapleural Gene-Mediated Cytotoxic Immunotherapy in Patients with Malignant Pleural Effusion. , Molecular therapy : the journal of the American Society of Gene Therapy, 26(5): 2018,1198-1205

Scherpereel Arnaud, Wallyn Frederic, Albelda Steven M, Munck Camille Novel therapies for malignant pleural mesothelioma. , The Lancet. Oncology, 19(3): 2018,e161-e172

Negorev Dmitri, Beier Ulf H, Zhang Tianyi, Quatromoni Jon G, Bhojnagarwala Pratik, Albelda Steven M, Singhal Sunil, Eruslanov Evgeniy, Lohoff Falk W, Levine Matthew H, Diamond Joshua M, Christie Jason D, Hancock Wayne W, Akimova Tatiana Human neutrophils can mimic myeloid-derived suppressor cells (PMN-MDSC) and suppress microbead or lectin-induced T cell proliferation through artefactual mechanisms. , Scientific reports, 8(1): 2018,3135

Moon Edmund K, Wang Liang-Chuan S, Bekdache Kheng, Lynn Rachel C, Lo Albert, Thorne Stephen H, Albelda Steven M Intra-tumoral delivery of CXCL11 via a vaccinia virus, but not by modified T cells, enhances the efficacy of adoptive T cell therapy and vaccines. , Oncoimmunology, 7(3): 2018,e1395997

Aggarwal Charu, Wang Xingmei, Ranganathan Anjana, Torigian Drew, Troxel Andrea, Evans Tracey, Cohen Roger B, Vaidya Bhavesh, Rao Chandra, Connelly Mark, Vachani Anil, Langer Corey, Albelda Steven Circulating tumor cells as a predictive biomarker in patients with small cell lung cancer undergoing chemotherapy. , Lung cancer (Amsterdam, Netherlands), 112: 2017,118-125

Pietrofesa RA, Woodruff P, Hwang WT, Patel P, Chatterjee S, Albelda SM, Christofidou-Solomidou M The synthetic lignan secoisolariciresinol diglucoside prevents asbestos-induced NLRP3 inflammasome activation in murine macrophages. , Oxidative medicine and cellular longevity, 2017: 2017,7395238

Akimova T, Zhang T, Negorev D, Singhal S, Stadanlick J, Rao A, Annunziata M, Levine MH, Beier UH, Diamond JM, Christie JD, Albelda SM, Eruslanov EB, Hancock WW Human lung tumor FOXP3+ Tregs upregulate four "Treg-locking" transcription factors. , JCI Insight, 2(16): 2017,pii 94075

Moon EK, Langer CJ, Albelda SM The era of checkpoint blockade in lung cancer: taking the brakes off the immune system. , Annals of the American Thoracic Society, 14(8): 2017,1248-1260

Newick K, O'Brien S, Moon E, Albelda SM CAR T Cell Therapy for Solid Tumors. , Annual Review of Medicine, 68: 2017,139-152